Table 2.
Baseline characteristics in each study group
| Patients with cryoglobulinemia (N = 56) |
Patients with SLE (N = 5) | Patients with CKD (hypertensive or diabetic) (N = 111) | Patients undergoing hemodialysis (N = 48) | Patients after kidney transplant (N = 12) | |
|---|---|---|---|---|---|
| Gender |
M: 20 pts. (35.8%) F: 36 pts. (64.2%) |
M: 0 pts. F: 5 pts. (100%) |
M: 51 pts. (46%) F: 60 pts. (54%) |
M: 27 pts. (56.2%) F: 21 pts. (43.8%) |
M: 7 pts. (58.3%) F: 5 (41.6%) |
| Fibrosis |
F2: 48 pts. (85.7%) F3: 5 pts. (8.9%) F4: 3 pts. (5.3%) |
F2: 4 pts. (80%) F3: 1 pts. (20%) F4: 0 pts |
F2: 54 pts. (48.6%) F3: 49 pts. (44.1%) F4: 8 pts. (7.2%) |
F2: 28 pts. (58.3%) F3: 12 pts. (25%) F4: 8 pts. (16.6%) |
F2: 5pts (41.6%) F3: 7 pts. (58.3%) F4: 0 pts |
| Stage of CKD |
Stage 2: 13 pts. (23.2%) Stage 3: 39 pts. (69.6%) Stage 4: 4 pts. (7.1%) |
Class 2 nephritis: 3 pts. (60%) Class 3 nephritis: 1 pts. (20%) Class 4 nephritis: 1 pts. (20%) |
Stage 2: 62 pts. (55.8%) Stage 3: 31 pts. (27.9%) Stage 4: 18 pts. (16.2%) |
Stage 2: 0 pts. Stage 3: 12 pts. (100%) Stage 4: 0 pts |
|
| Hemglobin |
Normal: 7 pts. (12.5%) Mild anemia: 49 pts. (87.5%) |
Normal: 2 pts. (40%) Mild anemia: 3 pts. (60%) |
Normal: 103 pts. (92.8%) Mild anemia: 8 pts. (7.2%) |
Normal: 0 pts. Mild anemia: 29 pts. (60.5%) Moderate anemia: 19 pts. (39.5%) |
Normal: 8 pts. (66.6%) Mild anemia: 4 pts. (33.3%) |